Marc‐Oliver Grimm
Jena University Hospital, Comprehensive Cancer Center Mainfranken
Papers
3
Total Citations
18
H-Index
3
About
Marc-Oliver Grimm is a leading urologic surgeon and clinical researcher whose work centers on advancing surgical outcomes for kidney and prostate cancers. He is best known for his pivotal role in the OpeRa trial, a landmark randomized controlled trial comparing open versus robotic-assisted partial nephrectomy in patients with intermediate- to high-complexity kidney tumors. This study, published in 2025 and already garnering 12 citations, provides critical Level 1 evidence on postoperative complications and has significant implications for surgical decision-making. Grimm has also made important contributions to prostate cancer care, investigating risk factors for vesicourethral anastomotic strictures following robotic-assisted radical prostatectomy, particularly in patients who have undergone radiotherapy. His research further explores how patient-specific factors—such as body mass index and prior abdominal surgeries—affect the technical steps and outcomes of robot-assisted radical prostatectomy. By combining rigorous trial methodology with a focus on real-world surgical challenges, Grimm’s work directly informs clinical practice and improves patient safety. His growing citation record reflects the high impact of his contributions to evidence-based urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3